April 1984
Volume 25, Issue 4
Articles  |   April 1984
Pharmacokinetics of subconjunctival liposome-encapsulated gentamicin in normal rabbit eyes.
Investigative Ophthalmology & Visual Science April 1984, Vol.25, 486-490. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M Barza, J Baum, F Szoka; Pharmacokinetics of subconjunctival liposome-encapsulated gentamicin in normal rabbit eyes.. Invest. Ophthalmol. Vis. Sci. 1984;25(4):486-490.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Subconjunctival injections of antibiotics produce very high corneal levels of drug that fall rapidly as the drug is dissipated. The authors studied the effects of liposome-encapsulation as a means of slowing release from the subconjunctival depot. Liposomes (0.1-1.0 micron) were made of phosphatidic acid, phosphatidylcholine, and alpha-tocopherol. The final suspension contained gentamicin 10 mg/ml with 60-70% encapsulated. Rabbits were given a single subconjunctival injection of liposome-encapsulated gentamicin, gentamicin with "empty" liposomes, or gentamicin alone. In each instance the dose of antibiotic was 5 mg. Gentamicin levels in the sclera and cornea, measured 3,9, and 24 hr after injection, were generally markedly higher with the liposome-encapsulated drug than with the other two preparations. The differences were 5- to 20-fold in the cornea at 24 hr and were statistically significant for temporal cornea. Liposome-encapsulation may be a useful means of extending the effects of a subconjunctival injection of antibiotic.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.